Stryker (NYSE:SYK) Reaches New 1-Year Low – Time to Sell?

Stryker Corporation (NYSE:SYK) shares hit a new 52-week low during trading on Monday . The company traded as low as $283.36 and last traded at $284.4610, with a volume of 62515 shares trading hands. The stock had previously closed at $285.47.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. BTIG Research lowered their price target on Stryker from $397.00 to $379.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Weiss Ratings cut Stryker from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, May 4th. Barclays decreased their target price on Stryker from $469.00 to $394.00 and set an “overweight” rating for the company in a research note on Monday, May 4th. Jefferies Financial Group reaffirmed a “buy” rating and set a $465.00 target price on shares of Stryker in a research note on Wednesday, March 4th. Finally, Leerink Partners initiated coverage on Stryker in a research note on Monday, April 13th. They set an “outperform” rating and a $410.00 target price for the company. Sixteen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $395.48.

Stryker Price Performance

The stock has a 50 day moving average of $334.48 and a two-hundred day moving average of $353.16. The stock has a market cap of $112.88 billion, a PE ratio of 34.11, a PEG ratio of 1.78 and a beta of 0.80. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The company had revenue of $6.02 billion during the quarter, compared to analysts’ expectations of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period in the prior year, the business posted $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Equities analysts anticipate that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%. Stryker’s dividend payout ratio (DPR) is currently 40.74%.

Insiders Place Their Bets

In related news, VP M Kathryn Fink sold 5,220 shares of Stryker stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $283.85, for a total value of $1,481,697.00. Following the transaction, the vice president owned 13,137 shares of the company’s stock, valued at approximately $3,728,937.45. This trade represents a 28.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 4.60% of the company’s stock.

Hedge Funds Weigh In On Stryker

A number of institutional investors have recently bought and sold shares of SYK. Norges Bank acquired a new stake in Stryker during the 4th quarter worth about $1,822,272,000. Auto Owners Insurance Co boosted its position in Stryker by 35,047.0% during the 4th quarter. Auto Owners Insurance Co now owns 2,914,741 shares of the medical technology company’s stock worth $1,024,444,000 after acquiring an additional 2,906,448 shares during the period. Wellington Management Group LLP boosted its position in Stryker by 22.6% during the 4th quarter. Wellington Management Group LLP now owns 6,493,276 shares of the medical technology company’s stock worth $2,282,192,000 after acquiring an additional 1,198,665 shares during the period. Corient Private Wealth LLC boosted its position in Stryker by 104.4% during the 2nd quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company’s stock worth $887,525,000 after acquiring an additional 1,146,998 shares during the period. Finally, Alliancebernstein L.P. boosted its position in Stryker by 13.3% during the 3rd quarter. Alliancebernstein L.P. now owns 6,338,050 shares of the medical technology company’s stock worth $2,342,987,000 after acquiring an additional 741,542 shares during the period. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.